Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
PLUR

PLUR - Pluri Inc Stock Price, Fair Value and News

$4.82+0.42 (+9.55%)
Delayed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

PLUR Price Action

Last 7 days

2.1%

Last 30 days

-4.7%

Last 90 days

-9.9%

Trailing 12 Months

5.7%

PLUR RSI Chart

PLUR Valuation

Market Cap

26.8M

Price/Earnings (Trailing)

-1.23

Price/Sales (Trailing)

44.8

Price/Free Cashflow

-1.61

PLUR Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

PLUR Fundamentals

PLUR Revenue

Revenue (TTM)

598.0K

Rev. Growth (Yr)

503.7%

Rev. Growth (Qtr)

239.58%

PLUR Earnings

Earnings (TTM)

-21.8M

Earnings Growth (Yr)

-18.56%

Earnings Growth (Qtr)

-2.67%

PLUR Profitability

Operating Margin

99.33%

Return on Equity

34.6K%

Return on Assets

-61.53%

Free Cashflow Yield

-62.17%

PLUR Investor Care

Shares Dilution (1Y)

7.21%

Diluted EPS (TTM)

-4.11

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024341.0K326.0K598.0K0
2023789.0K287.0K322.0K357.0K
202201.2M1.8M1.3M
20210000
20200000
201953.0K54.0K106.0K79.0K
2018982.3K50.0K51.0K52.0K
20170001.9M
20162.2M2.8M00
2015379.0K379.0K996.0K1.6M
2014480.0K379.0K379.0K379.0K
2013685.0K779.0K679.0K579.0K
20120716.0K757.0K721.0K
20110000
Get all data in R, Python etc through our Historical Stock Data APIs

About Pluri Inc

PLUR
Pluri Inc., a bio-technology company, creates cell-based products for commercial use. The company's technology platform, a 3D cell expansion system, advances novel cell-based solutions for a range of initiatives from medicine and climate change to food scarcity, animal cruelty, and other. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.
 CEO
 WEBSITEpluri-biotech.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES154

Pluri Inc Frequently Asked Questions

What is the ticker symbol for Pluri Inc? What does PLUR stand for in stocks?

PLUR is the stock ticker symbol of Pluri Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Pluri Inc (PLUR)?

As of Fri Dec 20 2024, market cap of Pluri Inc is 26.79 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PLUR stock?

You can check PLUR's fair value in chart for subscribers.

Is Pluri Inc a good stock to buy?

The fair value guage provides a quick view whether PLUR is over valued or under valued. Whether Pluri Inc is cheap or expensive depends on the assumptions which impact Pluri Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PLUR.

What is Pluri Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, PLUR's PE ratio (Price to Earnings) is -1.23 and Price to Sales (PS) ratio is 44.8. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PLUR PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Pluri Inc's stock?

In the past 10 years, Pluri Inc has provided -0.31 (multiply by 100 for percentage) rate of return.